{"id":114344,"date":"2026-07-21T13:33:57","date_gmt":"2026-07-21T08:03:57","guid":{"rendered":"https:\/\/vajiramandravi.com\/current-affairs\/?p=114344"},"modified":"2026-07-21T13:33:57","modified_gmt":"2026-07-21T08:03:57","slug":"qdenga-tak-003","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/current-affairs\/qdenga-tak-003\/","title":{"rendered":"QDENGA (TAK-003)"},"content":{"rendered":"<h2><b>QDENGA (TAK-003) Latest News<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The Drug Controller General of India (DCGI) recently granted market authorisation to Takeda Biopharmaceuticals India\u2019s QDENGA (TAK-003), making it the first dengue vaccine to be approved in the country.<\/span><\/p>\n<h2><b>About QDENGA (TAK-003)<\/b><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is a <\/span><b>dengue vaccine<\/b><span style=\"font-weight: 400;\"> developed by the<\/span><b> Japanese pharmaceutical company Takeda.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is the<\/span><b> first dengue vaccine<\/b><span style=\"font-weight: 400;\"> to be <\/span><b>approved in India.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The vaccine has been <\/span><b>approved <\/b><span style=\"font-weight: 400;\">for the prevention of dengue in <\/span><b>individuals aged four to 60.\u00a0<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">QDENGA is a <\/span><b>live-attenuated (weakened) tetravalent vaccine<\/b><span style=\"font-weight: 400;\"> designed to provide <\/span><b>protection against all four dengue virus serotypes (DENV-1 to DENV-4).<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It is administered as a <\/span><b>two-dose regimen<\/b><span style=\"font-weight: 400;\">, with doses given <\/span><b>three months apart.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The vaccine can be <\/span><b>administered irrespective<\/b><span style=\"font-weight: 400;\"> of whether an<\/span><b> individual has had a previous dengue infection<\/b><span style=\"font-weight: 400;\"> and <\/span><b>does not require pre-vaccination screening.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The vaccine has already been <\/span><b>approved in more than 40 countries,<\/b><span style=\"font-weight: 400;\"> including the European Union, the United Kingdom, Brazil, Indonesia, and Argentina.\u00a0<\/span><\/li>\n<\/ul>\n<h3><b>\u00a0What is Dengue?<\/b><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\"><strong><a href=\"https:\/\/vajiramandravi.com\/current-affairs\/what-is-dengue\/\" target=\"_blank\">Dengue<\/a><\/strong> disease is a<\/span><b> mosquito-borne tropical disease<\/b><span style=\"font-weight: 400;\"> caused by the<\/span><b> dengue virus, <\/b><span style=\"font-weight: 400;\">leading to mild,<\/span><b> flu-like symptoms<\/b><span style=\"font-weight: 400;\"> in most people.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">However, a small number of patients develop<\/span><b> severe disease,<\/b><span style=\"font-weight: 400;\"> with potentially<\/span><b> fatal bleeding and organ damage.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It poses a significant<\/span><b> global public health threat<\/b><span style=\"font-weight: 400;\">, with prevalence in over <\/span><b>125 countries.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>India <\/b><span style=\"font-weight: 400;\">accounts for nearly <\/span><b>one-third o<\/b><span style=\"font-weight: 400;\">f the global dengue burden.<\/span><\/li>\n<\/ul>\n<p><b>Source: <\/b><a href=\"https:\/\/www.thehindu.com\/sci-tech\/health\/india-approves-first-dengue-vaccine-for-individuals-aged-4-to-60-years\/article71244651.ece\" target=\"_blank\" rel=\"nofollow noopener\"><b>TH<\/b><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>QDENGA (TAK-003) is a dengue vaccine developed by the Japanese pharmaceutical company Takeda. Read more about QDENGA (TAK-003) Vaccine, Latest News.<\/p>\n","protected":false},"author":24,"featured_media":114319,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[8835],"class_list":["post-114344","post","type-post","status-publish","format-standard","has-post-thumbnail","category-upsc-prelims-current-affairs","tag-qdenga-tak-003","no-featured-image-padding"],"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/114344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/comments?post=114344"}],"version-history":[{"count":4,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/114344\/revisions"}],"predecessor-version":[{"id":114367,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/posts\/114344\/revisions\/114367"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media\/114319"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/media?parent=114344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/categories?post=114344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/current-affairs\/wp-json\/wp\/v2\/tags?post=114344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}